|
G
|
Adipoq
|
adiponectin, C1Q and collagen domain containing
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]]; zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]] zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]
|
CTD |
PMID:20052772 PMID:20861358 |
|
NCBI chr11:91,226,524...91,240,244
Ensembl chr11:91,226,180...91,240,169
|
|
G
|
Agt
|
angiotensinogen
|
multiple interactions
|
ISO
|
[zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]]
|
CTD |
PMID:20523338 |
|
NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
|
|
G
|
Akt1
|
AKT serine/threonine kinase 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [olprinone results in increased activity of AKT1 protein]
|
CTD |
PMID:19387321 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
G
|
Alad
|
aminolevulinate dehydratase
|
affects abundance
|
ISO
|
ALAD gene SNP affects the abundance of zinc protoporphyrin
|
CTD |
PMID:25963508 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
G
|
Alb
|
albumin
|
multiple interactions
|
ISO
|
ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]]; ALB protein inhibits the reaction [zinc protoporphyrin results in increased expression of HMOX1 protein] zinc protoporphyrin inhibits the reaction [ALB protein results in increased expression of HMOX1 protein]; zinc protoporphyrin promotes the reaction [ALB protein results in increased expression of TIMP1 protein]
|
CTD |
PMID:19376148 PMID:21163135 |
|
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,891,582...17,911,865
|
|
G
|
Alms1
|
ALMS1, centrosome and basal body associated protein
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of ALMS1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 4:119,683,085...119,783,471
Ensembl chr 4:119,683,076...119,783,471
|
|
G
|
Ap2a1
|
adaptor related protein complex 2 subunit alpha 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of AP2A1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 1:104,520,789...104,550,655
Ensembl chr 1:104,520,792...104,550,655
|
|
G
|
Ap3d1
|
adaptor related protein complex 3 subunit delta 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of AP3D1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:9,620,968...9,656,342
|
|
G
|
Asf1a
|
anti-silencing function 1A histone chaperone
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of ASF1A mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr20:33,436,632...33,451,478
Ensembl chr20:33,436,707...33,449,639
|
|
G
|
Bach1
|
BTB domain and CNC homolog 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA]]; zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]]; zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in increased expression of PTGS2 mRNA]]; zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in increased expression of PTGS2 protein]]
|
CTD |
PMID:38573338 |
|
NCBI chr11:40,425,721...40,461,118
Ensembl chr11:40,425,664...40,461,277
|
|
G
|
Bax
|
BCL2 associated X, apoptosis regulator
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of BAX protein]]; zinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of BAX protein]] zinc protoporphyrin inhibits the reaction [Cisplatin results in increased expression of BAX protein] zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in increased expression of BAX mRNA]]
|
CTD |
PMID:22763982 PMID:27523796 PMID:27815112 PMID:32621855 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
|
|
G
|
Bcl2
|
BCL2, apoptosis regulator
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]; zinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]] zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]]
|
CTD |
PMID:22763982 PMID:27523796 PMID:32621855 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
|
|
G
|
Bcl2l1
|
Bcl2-like 1
|
multiple interactions increases expression
|
EXP ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of BCL2L1 protein] zinc protoporphyrin results in increased expression of BCL2L1 protein
|
CTD |
PMID:20357190 PMID:27829220 |
|
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
|
|
G
|
Bcl2l11
|
Bcl2-like 11
|
increases expression
|
ISO
|
zinc protoporphyrin results in increased expression of BCL2L11 protein
|
CTD |
PMID:27829220 |
|
NCBI chr 3:135,820,042...135,857,330
Ensembl chr 3:135,817,562...135,960,695
|
|
G
|
Bglap
|
bone gamma-carboxyglutamate protein
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [15-deoxyprostaglandin J2 results in decreased expression of BGLAP mRNA]; zinc protoporphyrin inhibits the reaction [Hemin results in decreased expression of BGLAP mRNA]
|
CTD |
PMID:20020468 |
|
NCBI chr 2:176,136,341...176,137,318
Ensembl chr 2:176,136,341...176,137,318
|
|
G
|
Birc3
|
baculoviral IAP repeat-containing 3
|
multiple interactions
|
ISO
|
zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BIRC3 protein]
|
CTD |
PMID:18508827 |
|
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
|
|
G
|
Calca
|
calcitonin-related polypeptide alpha
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [monophosphoryl lipid A results in increased expression of CALCA mRNA]
|
CTD |
PMID:11738242 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
G
|
Cand1
|
cullin-associated and neddylation-dissociated 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of CAND1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:56,551,394...56,604,655
|
|
G
|
Casp1
|
caspase 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Dexmedetomidine inhibits the reaction [Ropivacaine results in increased cleavage of CASP1 protein]]
|
CTD |
PMID:36858639 |
|
NCBI chr 8:10,746,338...10,882,295
Ensembl chr 8:10,746,333...10,882,275
|
|
G
|
Casp3
|
caspase 3
|
multiple interactions decreases activity increases cleavage
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [[Glucose deficiency co-treated with Simvastatin] results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; zinc protoporphyrin promotes the reaction [T-2 Toxin results in increased activity of CASP3 protein] zinc protoporphyrin results in decreased activity of CASP3 protein zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of CASP3 protein]; zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in increased expression of CASP3 mRNA]]; zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased cleavage of CASP3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased cleavage of CASP3 protein] zinc protoporphyrin inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased activity of CASP3 protein]]; zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [FASLG protein results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; zinc protoporphyrin promotes the reaction [arsenic trioxide results in increased activity of CASP3 protein]; zinc protoporphyrin promotes the reaction [quinocetone results in increased activity of CASP3 protein] zinc protoporphyrin results in increased cleavage of CASP3 protein
|
CTD |
PMID:16051694 PMID:17928392 PMID:20357190 PMID:21295052 PMID:22763982 PMID:25003661 PMID:26747958 PMID:27375190 PMID:27815112 PMID:28025122 PMID:29432840 PMID:30261164 PMID:32621855 More...
|
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
G
|
Casp8
|
caspase 8
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP8 protein]
|
CTD |
PMID:16051694 |
|
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
|
|
G
|
Casp9
|
caspase 9
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased activity of CASP9 protein]]; zinc protoporphyrin promotes the reaction [quinocetone results in increased activity of CASP9 protein] zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased activity of CASP9 protein]]; zinc protoporphyrin promotes the reaction [T-2 Toxin results in increased activity of CASP9 protein]
|
CTD |
PMID:27375190 PMID:29432840 PMID:30261164 |
|
Ensembl chr 5:159,391,188...159,409,648
|
|
G
|
Cat
|
catalase
|
multiple interactions
|
EXP ISO
|
zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in decreased expression of CAT protein]] zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of CAT protein]]
|
CTD |
PMID:32621855 PMID:35691465 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
G
|
Ccdc6
|
coiled-coil domain containing 6
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of CCDC6 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr20:18,431,243...18,527,227
Ensembl chr20:18,431,243...18,527,227
|
|
G
|
Ccl2
|
C-C motif chemokine ligand 2
|
multiple interactions
|
EXP ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of CCL2 protein]; zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of CCL2 mRNA] zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of CCL2 protein]]
|
CTD |
PMID:20357190 PMID:23892052 PMID:35691465 |
|
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
|
|
G
|
Ccr7
|
C-C motif chemokine receptor 7
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CCR7 mRNA]
|
CTD |
PMID:33049506 |
|
NCBI chr10:84,594,399...84,604,514
Ensembl chr10:84,593,594...84,604,501
|
|
G
|
Cd40
|
CD40 molecule
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA]
|
CTD |
PMID:33049506 |
|
NCBI chr 3:174,209,113...174,224,592
Ensembl chr 3:174,209,719...174,224,847
|
|
G
|
Cd80
|
Cd80 molecule
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CD80 mRNA]
|
CTD |
PMID:33049506 |
|
NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
|
|
G
|
Cd83
|
CD83 molecule
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CD83 mRNA]
|
CTD |
PMID:33049506 |
|
NCBI chr17:21,093,281...21,113,223
Ensembl chr17:21,093,281...21,113,047
|
|
G
|
Cd86
|
CD86 molecule
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 mRNA]
|
CTD |
PMID:33049506 |
|
NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
|
|
G
|
Cdk13
|
cyclin-dependent kinase 13
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of CDK13 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr17:51,945,975...52,040,218
Ensembl chr17:51,946,701...52,037,257
|
|
G
|
Cdkn1a
|
cyclin-dependent kinase inhibitor 1A
|
multiple interactions
|
ISO
|
zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of and affects the localization of CDKN1A protein]
|
CTD |
PMID:18508827 |
|
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
|
|
G
|
Chd7
|
chromodomain helicase DNA binding protein 7
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of CHD7 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 5:26,609,245...26,792,736
Ensembl chr 5:26,609,407...26,792,734
|
|
G
|
Cmbl
|
carboxymethylenebutenolidase homolog
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of CMBL mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:84,242,512...84,301,880
|
|
G
|
Cxcl1
|
C-X-C motif chemokine ligand 1
|
increases expression
|
EXP
|
zinc protoporphyrin results in increased expression of CXCL1 mRNA
|
CTD |
PMID:25780291 |
|
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,477,549...17,479,811
|
|
G
|
Cxcl10
|
C-X-C motif chemokine ligand 10
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]]
|
CTD |
PMID:20861358 |
|
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
|
|
G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
increases expression
|
EXP
|
zinc protoporphyrin results in increased expression of CXCL2 mRNA
|
CTD |
PMID:25780291 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
G
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1
|
multiple interactions
|
EXP
|
[[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A1 protein
|
CTD |
PMID:26747958 |
|
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
|
|
G
|
Cyp1a2
|
cytochrome P450, family 1, subfamily a, polypeptide 2
|
multiple interactions
|
EXP
|
[[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP1A2 protein
|
CTD |
PMID:26747958 |
|
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:66,971,261...66,978,149
|
|
G
|
Cyp2b1
|
cytochrome P450, family 2, subfamily b, polypeptide 1
|
multiple interactions
|
EXP
|
[[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2B1 protein
|
CTD |
PMID:26747958 |
|
NCBI chr 1:90,646,098...90,669,762
|
|
G
|
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1
|
multiple interactions
|
EXP ISO
|
[[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2E1 mRNA; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of CYP2E1 protein; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 mRNA]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of CYP2E1 protein] zinc protoporphyrin inhibits the reaction [Quercetin inhibits the reaction [Ethanol results in increased expression of and results in increased activity of CYP2E1 protein]]; zinc protoporphyrin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer inhibits the reaction [Ethanol results in increased activity of CYP2E1 protein]]
|
CTD |
PMID:19325051 PMID:26747958 |
|
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:205,267,505...205,293,495
|
|
G
|
Dcun1d1
|
defective in cullin neddylation 1 domain containing 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of DCUN1D1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:120,649,445...120,700,879
Ensembl chr 2:120,649,445...120,700,870
|
|
G
|
Ddit3
|
DNA-damage inducible transcript 3
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased expression of DDIT3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of DDIT3 protein]
|
CTD |
PMID:26747958 |
|
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
|
|
G
|
Dhx29
|
DExH-box helicase 29
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of DHX29 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:46,293,901...46,344,652
Ensembl chr 2:46,293,677...46,344,948
|
|
G
|
Dusp10
|
dual specificity phosphatase 10
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 mRNA]; zinc protoporphyrin inhibits the reaction [andrographolide results in increased expression of DUSP10 protein]
|
CTD |
PMID:29165873 |
|
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:98,145,893...98,183,304
|
|
G
|
Eif2ak3
|
eukaryotic translation initiation factor 2 alpha kinase 3
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] results in increased phosphorylation of EIF2AK3 protein]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased phosphorylation of EIF2AK3 protein]
|
CTD |
PMID:26747958 |
|
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:104,363,833...104,425,268
|
|
G
|
Eml4
|
EMAP like 4
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of EML4 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:16,972,075...17,087,439
|
|
G
|
F2
|
coagulation factor II, thrombin
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer inhibits the reaction [F2 protein results in increased expression of PTGS2 protein]]; zinc protoporphyrin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer inhibits the reaction [F2 protein results in increased secretion of Dinoprostone]]
|
CTD |
PMID:26385185 |
|
NCBI chr 3:98,051,958...98,065,246
Ensembl chr 3:98,051,960...98,065,246
|
|
G
|
Faslg
|
Fas ligand
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [FASLG protein results in increased activity of CASP8 protein]; zinc protoporphyrin inhibits the reaction [FASLG protein results in increased cleavage of CASP3 protein]
|
CTD |
PMID:16051694 |
|
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
|
|
G
|
Fbxw12
|
F-box and WD repeat domain containing 12
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of FBXW12 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 8:118,660,777...118,680,565
Ensembl chr 8:118,660,605...118,680,572
|
|
G
|
Fgfr1
|
Fibroblast growth factor receptor 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of FGFR1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr16:73,194,631...73,249,855
Ensembl chr16:73,194,631...73,249,855
|
|
G
|
Flt1
|
Fms related receptor tyrosine kinase 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Diazoxide inhibits the reaction [Oxygen deficiency results in increased expression of FLT1 protein]]
|
CTD |
PMID:25371888 |
|
NCBI chr12:12,333,050...12,504,750
Ensembl chr12:12,333,430...12,504,750
|
|
G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
increases expression
|
ISO
|
zinc protoporphyrin results in increased expression of FOS mRNA
|
CTD |
PMID:10381381 |
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
G
|
Fut4
|
fucosyltransferase 4
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of FUT4 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 8:19,868,178...19,872,139
Ensembl chr 8:19,868,079...19,872,436
|
|
G
|
Glul
|
glutamate-ammonia ligase
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Ammonia results in decreased activity of GLUL protein]]; zinc protoporphyrin inhibits the reaction [Resveratrol results in increased activity of GLUL protein]
|
CTD |
PMID:26318273 |
|
NCBI chr13:68,519,500...68,585,554
Ensembl chr13:68,576,067...68,585,520
|
|
G
|
Gpr132
|
G protein-coupled receptor 132
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of GPR132 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:137,745,142...137,763,037
Ensembl chr 6:137,745,241...137,763,157
|
|
G
|
Gpx1
|
glutathione peroxidase 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX1 protein]
|
CTD |
PMID:36696656 |
|
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
|
|
G
|
Gpx4
|
glutathione peroxidase 4
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein] zinc protoporphyrin inhibits the reaction [Cadmium results in decreased expression of GPX4 protein]
|
CTD |
PMID:36696656 PMID:39025289 |
|
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
|
|
G
|
Gsdmd
|
gasdermin D
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Dexmedetomidine inhibits the reaction [Ropivacaine results in increased cleavage of GSDMD protein]]
|
CTD |
PMID:36858639 |
|
NCBI chr 7:109,423,209...109,427,771
Ensembl chr 7:109,422,910...109,430,722
|
|
G
|
Gucy1a1
|
guanylate cyclase 1 soluble subunit alpha 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]]
|
CTD |
PMID:19466990 |
|
NCBI chr 2:169,716,684...169,780,360
Ensembl chr 2:169,716,709...169,779,737
|
|
G
|
Gucy1b1
|
guanylate cyclase 1 soluble subunit beta 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 binds to GUCY1B1 protein]; zinc protoporphyrin inhibits the reaction [BAY 58-2667 inhibits the reaction [Heme deficiency results in decreased activity of [GUCY1A1 protein binds to GUCY1B1 protein]]]
|
CTD |
PMID:19466990 |
|
NCBI chr 2:169,646,897...169,697,060
Ensembl chr 2:169,646,898...169,696,987
|
|
G
|
Haus2
|
HAUS augmin like complex subunit 2
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of HAUS2 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 3:128,006,894...128,019,730
Ensembl chr 3:128,006,932...128,019,729
|
|
G
|
Havcr1
|
hepatitis A virus cellular receptor 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [Cadmium results in increased expression of HAVCR1 protein]
|
CTD |
PMID:39025289 |
|
NCBI chr10:31,619,914...31,652,955
Ensembl chr10:31,619,897...31,653,268
|
|
G
|
Hfe
|
homeostatic iron regulator
|
affects abundance
|
ISO
|
HFE gene polymorphism affects the abundance of zinc protoporphyrin
|
CTD |
PMID:25963508 |
|
NCBI chr17:41,841,302...41,849,359
Ensembl chr17:41,841,252...41,851,208
|
|
G
|
Hif1a
|
hypoxia inducible factor 1 subunit alpha
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [HIF1A protein results in increased activity of SOD2 protein]
|
CTD |
PMID:17066447 |
|
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:98,359,910...98,405,323
|
|
G
|
Hmgb1
|
high mobility group box 1
|
multiple interactions
|
EXP ISO
|
zinc protoporphyrin promotes the reaction [lead acetate results in increased expression of HMGB1 mRNA] zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]]
|
CTD |
PMID:29447957 PMID:30261164 |
|
NCBI chr12:11,009,236...11,015,941
Ensembl chr16:39,039,050...39,041,327 Ensembl chr12:39,039,050...39,041,327
|
|
G
|
Hmox1
|
heme oxygenase 1
|
multiple interactions increases expression decreases activity affects expression decreases expression
|
ISO EXP
|
[zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [cobaltiprotoporphyrin results in increased expression of TP53 protein]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] which results in increased susceptibility to 2-butenal; [zinc protoporphyrin results in decreased activity of HMOX1 protein] which results in increased susceptibility to Arsenic Trioxide; [zinc protoporphyrin results in decreased activity of HMOX1] which results in decreased susceptibility to peoniflorin; zinc protoporphyrin analog inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [[15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of and results in increased activity of HMOX1 protein] which results in increased abundance of Iron]; zinc protoporphyrin inhibits the reaction [[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [Ethanol results in decreased abundance of Glutathione]]; zinc protoporphyrin inhibits the reaction [[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [Ethanol results in increased abundance of Malondialdehyde]]; zinc protoporphyrin inhibits the reaction [[cobaltiprotoporphyrin results in increased expression of HMOX1 protein] which results in decreased susceptibility to Ethanol]; zinc protoporphyrin inhibits the reaction [ALB protein results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Cilostazol results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Cilostazol results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased activity of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Dexmedetomidine promotes the reaction [Ropivacaine results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]]; zinc protoporphyrin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of HMOX1 protein]; zinc protoporphyrin results in decreased expression of and results in decreased activity of HMOX1 protein; zinc protoporphyrin results in increased expression of and results in decreased activity of HMOX1 protein [zinc protoporphyrin co-treated with Hemin] results in increased expression of HMOX1 mRNA; [zinc protoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; ALB protein inhibits the reaction [zinc protoporphyrin results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HMOX1 mRNA]]; zinc protoporphyrin inhibits the reaction [8-oxoberberine promotes the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [[Lipopolysaccharides co-treated with 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone] results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [[Simvastatin co-treated with Lipopolysaccharides] results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Cisplatin results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Glucose deficiency promotes the reaction [Simvastatin results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein results in increased abundance of Superoxides]; zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Resveratrol inhibits the reaction [Doxorubicin results in decreased expression of and results in decreased activity of HMOX1 protein]] [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of HMOX1 mRNA; [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with zinc protoporphyrin] results in increased expression of HMOX1 mRNA; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [Resveratrol results in increased abundance of Glutathione]; [zinc protoporphyrin results in decreased activity of HMOX1 protein] which results in decreased susceptibility to Resveratrol; Hemin inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 mRNA]]; Hemin inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Cadmium results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Hemin promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 mRNA]]; zinc protoporphyrin inhibits the reaction [Hemin promotes the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [HMOX1 protein results in increased abundance of Superoxides]; zinc protoporphyrin inhibits the reaction [lead acetate results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [olprinone results in increased activity of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [perflexane promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of and results in increased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased activity of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Propofol promotes the reaction [Glucose results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Sildenafil Citrate results in increased expression of HMOX1 mRNA]; zinc protoporphyrin inhibits the reaction [Sildenafil Citrate results in increased expression of HMOX1 protein]; zinc protoporphyrin inhibits the reaction [Tadalafil promotes the reaction [Cisplatin results in increased expression of HMOX1 protein]]; zinc protoporphyrin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased activity of HMOX1 protein] zinc protoporphyrin results in increased expression of HMOX1 mRNA; zinc protoporphyrin results in increased expression of HMOX1 protein zinc protoporphyrin results in decreased activity of HMOX1; zinc protoporphyrin results in decreased activity of HMOX1 protein zinc protoporphyrin affects the expression of HMOX1 mRNA; zinc protoporphyrin affects the expression of HMOX1 protein zinc protoporphyrin results in decreased expression of HMOX1 mRNA; zinc protoporphyrin results in decreased expression of HMOX1 protein
|
CTD |
PMID:7524564 PMID:12352873 PMID:14649057 PMID:15602829 PMID:16462769 PMID:17292349 PMID:17627722 PMID:17928392 PMID:18006204 PMID:18042465 PMID:18073186 PMID:18508827 PMID:19019021 PMID:19136476 PMID:19376148 PMID:19387321 PMID:19608869 PMID:20052772 PMID:20056245 PMID:20131233 PMID:20357190 PMID:20360627 PMID:20523338 PMID:21163135 PMID:21238556 PMID:21253390 PMID:21295052 PMID:21315065 PMID:21327864 PMID:21382476 PMID:21448202 PMID:21518603 PMID:21660147 PMID:21690482 PMID:21925249 PMID:22118543 PMID:22763982 PMID:22859313 PMID:22864849 PMID:23403272 PMID:23525258 PMID:23691207 PMID:23704825 PMID:24003391 PMID:24810525 PMID:25780291 PMID:25824035 PMID:26747958 PMID:27523796 PMID:27815112 PMID:27829220 PMID:27830717 PMID:29447957 PMID:31356851 PMID:32621855 PMID:33049506 PMID:34029560 PMID:35691465 PMID:36696656 PMID:36858639 PMID:39025289 More...
|
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
G
|
Hmox2
|
heme oxygenase 2
|
decreases activity decreases expression
|
ISO EXP
|
zinc protoporphyrin results in decreased activity of HMOX2 protein zinc protoporphyrin results in decreased expression of HMOX2 protein
|
CTD |
PMID:21448202 PMID:25824035 |
|
NCBI chr10:11,303,512...11,337,640
Ensembl chr10:11,303,512...11,318,800
|
|
G
|
Hp1bp3
|
heterochromatin protein 1, binding protein 3
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of HP1BP3 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:155,719,115...155,746,325
|
|
G
|
Hsd11b1
|
hydroxysteroid 11-beta dehydrogenase 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of HSD11B1 mRNA]]
|
CTD |
PMID:27523796 |
|
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:107,257,239...107,327,432
|
|
G
|
Icam1
|
intercellular adhesion molecule 1
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]] zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA] zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of ICAM1 mRNA]
|
CTD |
PMID:19608869 PMID:23892052 PMID:33049506 |
|
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
|
|
G
|
Ifnb1
|
interferon beta 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA]]
|
CTD |
PMID:20861358 |
|
NCBI chr 5:108,066,650...108,067,487
Ensembl chr 5:108,066,650...108,067,487
|
|
G
|
Ifng
|
interferon gamma
|
multiple interactions increases expression
|
EXP
|
zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased expression of HMOX1 protein] zinc protoporphyrin results in increased expression of IFNG mRNA
|
CTD |
PMID:21295052 PMID:25780291 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
|
|
G
|
Il10
|
interleukin 10
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of IL10 mRNA]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of IL10 protein]; zinc protoporphyrin inhibits the reaction [perflexane inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of IL10 protein]]
|
CTD |
PMID:20056245 PMID:20360627 |
|
NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
|
|
G
|
Il12b
|
interleukin 12B
|
multiple interactions
|
ISO
|
zinc protoporphyrin promotes the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]]
|
CTD |
PMID:33049506 |
|
NCBI chr10:29,390,300...29,405,194
Ensembl chr10:29,389,905...29,405,194
|
|
G
|
Il18
|
interleukin 18
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Dexmedetomidine inhibits the reaction [Ropivacaine results in increased expression of IL18 protein]]; zinc protoporphyrin inhibits the reaction [Hemin results in decreased susceptibility to IL18 protein]
|
CTD |
PMID:18215737 PMID:36858639 |
|
NCBI chr 8:59,802,072...59,829,275
Ensembl chr 8:59,809,592...59,831,286
|
|
G
|
Il1b
|
interleukin 1 beta
|
multiple interactions increases expression
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [Cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]; zinc protoporphyrin inhibits the reaction [Dexmedetomidine inhibits the reaction [Ropivacaine results in increased expression of IL1B protein]] zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased cleavage of CASP3 protein]; zinc protoporphyrin inhibits the reaction [[IFNG protein co-treated with IL1B protein] results in increased expression of HMOX1 protein]; zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of IL1B mRNA] zinc protoporphyrin results in increased expression of IL1B mRNA zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL1B protein]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]]
|
CTD |
PMID:20131233 PMID:21295052 PMID:23892052 PMID:25780291 PMID:27523796 PMID:30261164 PMID:35691465 PMID:36858639 More...
|
|
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
|
|
G
|
Il23a
|
interleukin 23 subunit alpha
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased expression of IL23A mRNA]]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL23A protein]]
|
CTD |
PMID:33049506 |
|
NCBI chr 7:1,306,320...1,308,434
Ensembl chr 7:1,306,320...1,308,434
|
|
G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of IL6 protein]] zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; zinc protoporphyrin inhibits the reaction [manganese chloride promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]] zinc protoporphyrin results in increased expression of IL6 mRNA
|
CTD |
PMID:19608869 PMID:20131233 PMID:21963524 PMID:25780291 PMID:27523796 PMID:30261164 PMID:33049506 PMID:35691465 More...
|
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
G
|
Inpp5d
|
inositol polyphosphate-5-phosphatase D
|
decreases expression
|
EXP
|
zinc protoporphyrin results in decreased expression of INPP5D protein
|
CTD |
PMID:25780291 |
|
NCBI chr 9:95,735,533...95,840,584
Ensembl chr 9:95,735,530...95,840,589
|
|
G
|
Irak1
|
interleukin-1 receptor-associated kinase 1
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [IRAK1 protein binds to MYD88 protein]
|
CTD |
PMID:25780291 |
|
NCBI chr X:156,919,927...156,929,825
Ensembl chr X:156,920,081...156,929,825
|
|
G
|
Irak3
|
interleukin-1 receptor-associated kinase 3
|
decreases expression
|
EXP
|
zinc protoporphyrin results in decreased expression of IRAK3 protein
|
CTD |
PMID:25780291 |
|
NCBI chr 7:57,538,522...57,600,166
Ensembl chr 7:57,539,557...57,598,706
|
|
G
|
Itgam
|
integrin subunit alpha M
|
increases expression
|
ISO
|
zinc protoporphyrin results in increased expression of ITGAM protein
|
CTD |
PMID:22118543 |
|
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
|
|
G
|
Jun
|
Jun proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO
|
zinc protoporphyrin promotes the reaction [arsenic trioxide results in increased expression of JUN protein] zinc protoporphyrin results in increased expression of JUN protein
|
CTD |
PMID:27829220 |
|
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
|
|
G
|
Kcnab1
|
potassium voltage-gated channel subfamily A regulatory beta subunit 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCNAB1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:151,446,975...151,913,636
Ensembl chr 2:151,446,947...151,913,636
|
|
G
|
Kctd20
|
potassium channel tetramerization domain containing 20
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KCTD20 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr20:7,017,480...7,034,440
Ensembl chr20:7,017,502...7,034,441
|
|
G
|
Kidins220
|
kinase D-interacting substrate 220
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of KIDINS220 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:47,346,790...47,435,599
Ensembl chr 6:47,346,832...47,431,865
|
|
G
|
Kitlg
|
KIT ligand
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KITLG mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 7:36,782,621...36,863,796
Ensembl chr 7:36,782,638...36,863,793
|
|
G
|
Kras
|
KRAS proto-oncogene, GTPase
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of KRAS mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
|
|
G
|
Larp1b
|
La ribonucleoprotein 1B
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LARP1B mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:125,860,935...125,897,189
Ensembl chr 2:125,863,997...125,897,189
|
|
G
|
Lcn2
|
lipocalin 2
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [Cadmium results in increased expression of LCN2 protein]
|
CTD |
PMID:39025289 |
|
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:36,078,436...36,081,842
|
|
G
|
Ldha
|
lactate dehydrogenase A
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Dexmedetomidine inhibits the reaction [Ropivacaine results in increased expression of LDHA protein]]
|
CTD |
PMID:36858639 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:106,502,182...106,517,521
|
|
G
|
Lnx1
|
ligand of numb-protein X 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LNX1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr14:33,868,517...33,971,217
Ensembl chr14:33,868,571...33,971,217
|
|
G
|
Lyrm7
|
LYR motif containing 7
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of LYRM7 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr10:38,964,299...38,983,628
Ensembl chr10:39,465,036...39,484,240
|
|
G
|
Macf1
|
microtubule-actin crosslinking factor 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of MACF1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 5:140,908,829...141,234,127
Ensembl chr 5:140,908,837...141,233,890
|
|
G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation
|
ISO
|
[zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK1 protein]] zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]; zinc protoporphyrin promotes the reaction [lipoteichoic acid results in increased phosphorylation of MAPK1 protein]; zinc protoporphyrin promotes the reaction [Peptidoglycan results in increased phosphorylation of MAPK1 protein] zinc protoporphyrin results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:19376148 PMID:20523338 PMID:27523796 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
ISO
|
[zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [neferine inhibits the reaction [AGT protein results in increased phosphorylation of MAPK3 protein]] zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]; zinc protoporphyrin promotes the reaction [lipoteichoic acid results in increased phosphorylation of MAPK3 protein]; zinc protoporphyrin promotes the reaction [Peptidoglycan results in increased phosphorylation of MAPK3 protein] zinc protoporphyrin results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:19376148 PMID:20523338 PMID:27523796 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
G
|
Mark2
|
microtubule affinity regulating kinase 2
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of MARK2 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 1:213,890,213...213,955,417
Ensembl chr 1:213,890,213...213,955,149
|
|
G
|
Mfn1
|
mitofusin 1
|
multiple interactions
|
EXP
|
Hemin inhibits the reaction [zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in decreased expression of MFN1 mRNA]]; Hemin inhibits the reaction [zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in decreased expression of MFN1 protein]]; zinc protoporphyrin inhibits the reaction [Hemin inhibits the reaction [Lipopolysaccharides results in decreased expression of MFN1 mRNA]]; zinc protoporphyrin inhibits the reaction [Hemin inhibits the reaction [Lipopolysaccharides results in decreased expression of MFN1 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in decreased expression of MFN1 mRNA]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in decreased expression of MFN1 protein]
|
CTD |
PMID:27830717 |
|
NCBI chr 2:117,240,525...117,288,017
Ensembl chr 2:117,241,759...117,290,190
|
|
G
|
Mllt3
|
MLLT3, super elongation complex subunit
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of MLLT3 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 5:107,305,008...107,561,352
Ensembl chr 5:107,284,766...107,561,352
|
|
G
|
Mmp2
|
matrix metallopeptidase 2
|
affects expression multiple interactions
|
EXP ISO
|
zinc protoporphyrin affects the expression of MMP2 zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP2 mRNA]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP2 protein]
|
CTD |
PMID:23704825 PMID:30076913 |
|
NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
|
|
G
|
Mmp9
|
matrix metallopeptidase 9
|
multiple interactions
|
ISO
|
zinc protoporphyrin promotes the reaction [arsenic trioxide results in increased expression of MMP9 protein] zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 mRNA]; zinc protoporphyrin inhibits the reaction [fisetin results in decreased expression of MMP9 protein]
|
CTD |
PMID:27829220 PMID:30076913 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
G
|
Mpo
|
myeloperoxidase
|
multiple interactions
|
EXP
|
zinc protoporphyrin inhibits the reaction [perflexane inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of MPO protein]]; zinc protoporphyrin promotes the reaction [Indomethacin results in increased activity of MPO protein]; zinc protoporphyrin promotes the reaction [Trinitrobenzenesulfonic Acid results in increased activity of MPO protein]
|
CTD |
PMID:17292349 PMID:20360627 PMID:23892052 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
G
|
Myd88
|
MYD88, innate immune signal transduction adaptor
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [IRAK1 protein binds to MYD88 protein]; zinc protoporphyrin promotes the reaction [TLR2 protein binds to MYD88 protein]; zinc protoporphyrin promotes the reaction [TLR4 protein binds to MYD88 protein]; zinc protoporphyrin promotes the reaction [TRAF6 protein binds to MYD88 protein]
|
CTD |
PMID:25780291 |
|
NCBI chr 8:127,952,161...127,956,230
Ensembl chr 8:127,952,161...127,956,230
|
|
G
|
Ncf1
|
neutrophil cytosolic factor 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to NCF1 protein]]]
|
CTD |
PMID:19608869 |
|
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:28,121,366...28,131,079
|
|
G
|
Nfe2l2
|
NFE2 like bZIP transcription factor 2
|
multiple interactions affects expression
|
EXP
|
zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in decreased expression of NFE2L2 mRNA]]; zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in decreased expression of NFE2L2 protein]]; zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of NFE2L2 protein] zinc protoporphyrin affects the expression of NFE2L2 mRNA; zinc protoporphyrin affects the expression of NFE2L2 protein
|
CTD |
PMID:23704825 PMID:25824035 PMID:38573338 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
|
|
G
|
Nfkb1
|
nuclear factor kappa B subunit 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides affects the localization of [RELA protein binds to NFKB1 protein]]]
|
CTD |
PMID:21925249 |
|
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
|
|
G
|
Nfkbia
|
NFKB inhibitor alpha
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [cilostazol results in increased expression of NFKBIA protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of NFKBIA protein] zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased degradation of NFKBIA protein]]
|
CTD |
PMID:20131233 PMID:21925249 |
|
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
|
|
G
|
Nos1
|
nitric oxide synthase 1
|
multiple interactions
|
EXP
|
[Sildenafil Citrate co-treated with zinc protoporphyrin] results in increased expression of NOS1 mRNA
|
CTD |
PMID:17627722 |
|
NCBI chr12:44,276,011...44,456,371
Ensembl chr12:44,287,614...44,371,837
|
|
G
|
Nos2
|
nitric oxide synthase 2
|
multiple interactions
|
ISO EXP
|
[zinc protoporphyrin results in increased expression of HMOX1 protein] inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; ALB protein inhibits the reaction [zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]]; lactacystin inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; lactacystin inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; lactacystin inhibits the reaction [zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]]; pyrazolanthrone inhibits the reaction [zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]; pyrazolanthrone inhibits the reaction [zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]]; pyrazolanthrone inhibits the reaction [zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]]; zinc protoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; zinc protoporphyrin inhibits the reaction [lipoteichoic acid results in increased expression of NOS2 protein]; zinc protoporphyrin inhibits the reaction [Peptidoglycan results in increased expression of NOS2 protein]; zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]] [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of NOS2 mRNA; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of NOS2 protein; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of NOS2 protein]; zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in increased expression of NOS2 mRNA]]; zinc protoporphyrin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer inhibits the reaction [Ethanol results in increased expression of NOS2 mRNA]]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 mRNA]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of NOS2 protein]
|
CTD |
PMID:19376148 PMID:20357190 PMID:21925249 PMID:26460608 PMID:26747958 PMID:32621855 More...
|
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
|
|
G
|
Pde4dip
|
phosphodiesterase 4D interacting protein
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PDE4DIP mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:187,981,878...188,178,869
|
|
G
|
Pgf
|
placental growth factor
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PGF mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:110,547,165...110,557,747
Ensembl chr 6:110,547,153...110,557,747
|
|
G
|
Polr3k
|
RNA polymerase III subunit K
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of POLR3K mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 3:189,360,349...189,364,546
Ensembl chr 3:189,360,171...189,366,697
|
|
G
|
Pparg
|
peroxisome proliferator-activated receptor gamma
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [cilostazol results in increased activity of PPARG protein]; zinc protoporphyrin inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]
|
CTD |
PMID:21660147 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
|
|
G
|
Ppil1
|
peptidylprolyl isomerase like 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of PPIL1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr20:7,303,919...7,323,962
Ensembl chr20:7,303,922...7,318,781
|
|
G
|
Prdx2
|
peroxiredoxin 2
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PRDX2 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:40,084,430...40,091,006
|
|
G
|
Prr11
|
proline rich 11
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PRR11 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr10:72,396,127...72,440,643
Ensembl chr10:72,398,667...72,418,275
|
|
G
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [tricarbonyldichlororuthenium (II) dimer inhibits the reaction [F2 protein results in increased expression of PTGS2 protein]]; zinc protoporphyrin promotes the reaction [Arsenic Trioxide results in increased expression of PTGS2] zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]]; zinc protoporphyrin promotes the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in increased expression of PTGS2 mRNA]]; zinc protoporphyrin affects the reaction [BACH1 protein affects the reaction [Doxorubicin results in increased expression of PTGS2 protein]]; zinc protoporphyrin inhibits the reaction [Cadmium results in increased expression of PTGS2 protein]
|
CTD |
PMID:23649692 PMID:24003391 PMID:26385185 PMID:30261164 PMID:38573338 PMID:39025289 More...
|
|
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
|
|
G
|
Ptpn12
|
protein tyrosine phosphatase, non-receptor type 12
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of PTPN12 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 4:14,913,071...14,985,084
Ensembl chr 4:14,913,218...14,985,284
|
|
G
|
Ptpro
|
protein tyrosine phosphatase, receptor type, O
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of PTPRO mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 4:171,895,104...172,105,911
Ensembl chr 4:171,895,232...172,105,903
|
|
G
|
Rap2c
|
RAP2C, member of RAS oncogene family
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RAP2C mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr X:135,388,881...135,401,998
Ensembl chr X:135,388,882...135,401,998
|
|
G
|
Rela
|
RELA proto-oncogene, NF-kB subunit
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of RELA protein]]; zinc protoporphyrin inhibits the reaction [Curcumin inhibits the reaction [quinocetone results in increased expression of RELA mRNA]]; zinc protoporphyrin promotes the reaction [quinocetone results in increased expression of RELA mRNA] zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of RELA protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased localization of and results in increased activity of RELA protein]]; zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides affects the localization of [RELA protein binds to NFKB1 protein]]]; zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein modified form]] zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of RELA protein]
|
CTD |
PMID:19608869 PMID:20131233 PMID:20357190 PMID:21925249 PMID:27375190 PMID:27523796 More...
|
|
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
|
|
G
|
Rgcc
|
regulator of cell cycle
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of RGCC mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr15:61,071,574...61,084,408
Ensembl chr15:61,071,574...61,084,408
|
|
G
|
Scaf11
|
SR-related CTD-associated factor 11
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of SCAF11 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 7:129,450,872...129,503,280
Ensembl chr 7:129,417,955...129,503,280
|
|
G
|
Scamp1
|
secretory carrier membrane protein 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SCAMP1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:27,168,863...27,251,637
Ensembl chr 2:27,168,864...27,251,742
|
|
G
|
Sec23b
|
Sec23 homolog B, COPII coat complex component
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SEC23B mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 3:152,392,340...152,434,813
Ensembl chr 3:152,392,308...152,434,800
|
|
G
|
Sel1l
|
SEL1L adaptor subunit of SYVN1 ubiquitin ligase
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SEL1L mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:116,466,163...116,510,436
Ensembl chr 6:116,466,163...116,510,578
|
|
G
|
Sirt1
|
sirtuin 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Fenofibrate results in increased expression of SIRT1 protein]
|
CTD |
PMID:34520103 |
|
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,305,476...25,328,000
|
|
G
|
Slc22a3
|
solute carrier family 22 member 3
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of SLC22A3 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:50,783,218...50,872,353
|
|
G
|
Slc35e1
|
solute carrier family 35, member E1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of SLC35E1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr16:17,350,938...17,364,185
Ensembl chr16:17,385,030...17,397,310
|
|
G
|
Smcr8
|
SMCR8-C9orf72 complex subunit
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SMCR8 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr10:45,957,146...45,968,388
Ensembl chr10:45,957,104...45,968,389
|
|
G
|
Sod2
|
superoxide dismutase 2
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SOD2 mRNA; zinc protoporphyrin inhibits the reaction [HIF1A protein results in increased activity of SOD2 protein]
|
CTD |
PMID:17066447 PMID:22839698 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
|
|
G
|
Sptbn1
|
spectrin, beta, non-erythrocytic 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of SPTBN1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr14:108,042,629...108,217,884
Ensembl chr14:108,042,629...108,217,836
|
|
G
|
Src
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to NCF1 protein]]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to TNFRSF1A protein]]]
|
CTD |
PMID:19608869 |
|
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
|
|
G
|
Ssbp3
|
single stranded DNA binding protein 3
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of SSBP3 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 5:126,920,145...127,057,968
Ensembl chr 5:126,919,120...127,056,799
|
|
G
|
St3gal1
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of ST3GAL1 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 7:100,734,300...100,802,443
Ensembl chr 7:100,734,300...100,745,242
|
|
G
|
Stat1
|
signal transducer and activator of transcription 1
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [Ozone results in increased phosphorylation of STAT1 protein]
|
CTD |
PMID:19061877 |
|
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
|
|
G
|
Stat3
|
signal transducer and activator of transcription 3
|
multiple interactions
|
EXP ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]]; zinc protoporphyrin inhibits the reaction [Propofol inhibits the reaction [Glucose results in decreased phosphorylation of STAT3 protein]] zinc protoporphyrin inhibits the reaction [Nicotine results in increased phosphorylation of STAT3 protein]
|
CTD |
PMID:24095726 PMID:24810525 |
|
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
|
|
G
|
Tgfb1
|
transforming growth factor, beta 1
|
affects expression increases expression decreases secretion
|
EXP
|
zinc protoporphyrin affects the expression of TGFB1 zinc protoporphyrin results in increased expression of TGFB1 protein zinc protoporphyrin results in decreased secretion of TGFB1 protein
|
CTD |
PMID:21163135 PMID:23525258 PMID:23704825 |
|
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
|
|
G
|
Timp1
|
TIMP metallopeptidase inhibitor 1
|
affects expression multiple interactions
|
EXP ISO
|
zinc protoporphyrin affects the expression of TIMP1 zinc protoporphyrin promotes the reaction [ALB protein results in increased expression of TIMP1 protein]
|
CTD |
PMID:21163135 PMID:23704825 |
|
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:3,766,510...3,771,135
|
|
G
|
Tlr2
|
toll-like receptor 2
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [TLR2 protein binds to MYD88 protein]
|
CTD |
PMID:25780291 |
|
NCBI chr 2:171,499,189...171,504,831
Ensembl chr 2:171,497,060...171,520,194
|
|
G
|
Tlr4
|
toll-like receptor 4
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [TLR4 protein binds to MYD88 protein]
|
CTD |
PMID:25780291 |
|
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:85,161,192...85,175,007
|
|
G
|
Tnf
|
tumor necrosis factor
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [cilostazol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; zinc protoporphyrin inhibits the reaction [cilostazol results in decreased susceptibility to TNF protein]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to NCF1 protein]]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to TNFRSF1A protein]]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of IL6 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] zinc protoporphyrin inhibits the reaction [8-oxoberberine inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of TNF protein]]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; zinc protoporphyrin inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased localization of and results in increased activity of RELA protein]]; zinc protoporphyrin inhibits the reaction [manganese chloride promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]]; zinc protoporphyrin inhibits the reaction [Nicotine inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; zinc protoporphyrin inhibits the reaction [sesamol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; zinc protoporphyrin inhibits the reaction [Simvastatin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]] [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of TNF mRNA; [[[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] co-treated with Ethanol] co-treated with zinc protoporphyrin] results in increased expression of TNF protein; zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; zinc protoporphyrin inhibits the reaction [naringenin results in decreased activity of TNF protein]; zinc protoporphyrin inhibits the reaction [perflexane inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]]; zinc protoporphyrin inhibits the reaction [Tadalafil inhibits the reaction [Cisplatin results in increased expression of TNF protein]]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of TNF mRNA]; zinc protoporphyrin promotes the reaction [[[Oxygen deficiency co-treated with Blood Glucose deficiency] co-treated with [Oxygen co-treated with Blood Glucose]] results in increased expression of TNF protein]
|
CTD |
PMID:19608869 PMID:20052772 PMID:20131233 PMID:20360627 PMID:21660147 PMID:21925249 PMID:21963524 PMID:22709785 PMID:24095726 PMID:26747958 PMID:30261164 PMID:32621855 PMID:33049506 PMID:35691465 More...
|
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
|
|
G
|
Tnfrsf1a
|
TNF receptor superfamily member 1A
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein promotes the reaction [SRC protein binds to TNFRSF1A protein]]]
|
CTD |
PMID:19608869 |
|
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
|
|
G
|
Tnrc6a
|
trinucleotide repeat containing adaptor 6A
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of TNRC6A mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 1:186,992,457...187,146,764
Ensembl chr 1:186,992,504...187,146,756
|
|
G
|
Tollip
|
toll interacting protein
|
decreases expression
|
EXP
|
zinc protoporphyrin results in decreased expression of TOLLIP protein
|
CTD |
PMID:25780291 |
|
NCBI chr 1:206,391,120...206,413,809
Ensembl chr 1:206,380,308...206,411,988
|
|
G
|
Tp53
|
tumor protein p53
|
multiple interactions
|
ISO EXP
|
[zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [cobaltiprotoporphyrin results in increased expression of TP53 protein] zinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in increased expression of TRP53 protein]] zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in decreased expression of TP53 protein]
|
CTD |
PMID:18042465 PMID:20357190 PMID:22763982 |
|
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
|
|
G
|
Traf6
|
TNF receptor associated factor 6
|
multiple interactions
|
EXP
|
zinc protoporphyrin promotes the reaction [TRAF6 protein binds to MYD88 protein]
|
CTD |
PMID:25780291 |
|
NCBI chr 3:108,418,537...108,443,330
Ensembl chr 3:108,418,513...108,443,328
|
|
G
|
Ubxn2a
|
UBX domain protein 2A
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of UBXN2A mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 6:33,603,804...33,645,958
Ensembl chr 6:33,603,804...33,632,202 Ensembl chr20:33,603,804...33,632,202
|
|
G
|
Usp13
|
ubiquitin specific peptidase 13
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP13 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:117,502,811...117,617,049
Ensembl chr 2:117,505,122...117,630,161
|
|
G
|
Usp34
|
ubiquitin specific peptidase 34
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of USP34 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr14:101,487,110...101,677,519
Ensembl chr14:101,487,153...101,678,632
|
|
G
|
Vcam1
|
vascular cell adhesion molecule 1
|
multiple interactions
|
ISO EXP
|
zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 mRNA]]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]]; zinc protoporphyrin inhibits the reaction [HMOX1 protein inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]] zinc protoporphyrin promotes the reaction [Indomethacin results in increased expression of VCAM1 mRNA]
|
CTD |
PMID:19608869 PMID:23892052 |
|
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:206,723,044...206,742,801
|
|
G
|
Vdr
|
vitamin D receptor
|
affects abundance
|
ISO
|
VDR gene polymorphism affects the abundance of zinc protoporphyrin
|
CTD |
PMID:25963508 |
|
NCBI chr 7:130,864,764...130,916,757
Ensembl chr 7:130,866,745...130,916,757
|
|
G
|
Vps33a
|
VPS33A core subunit of CORVET and HOPS complexes
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of VPS33A mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr12:38,685,484...38,710,668
Ensembl chr12:38,685,538...38,712,277
|
|
G
|
Wsb2
|
WD repeat and SOCS box-containing 2
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of WSB2 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr12:44,878,483...44,899,474
Ensembl chr12:44,878,509...44,899,474
|
|
G
|
Zfp36
|
zinc finger protein 36
|
multiple interactions
|
ISO
|
zinc protoporphyrin inhibits the reaction [[Nicotine co-treated with Lipopolysaccharides] results in increased expression of ZFP36 mRNA]; zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of ZFP36 mRNA]; zinc protoporphyrin inhibits the reaction [Hemin results in increased expression of ZFP36 mRNA]; zinc protoporphyrin inhibits the reaction [Nicotine results in increased expression of ZFP36 mRNA]
|
CTD |
PMID:24095726 |
|
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:92,796,628...92,799,108
|
|
G
|
Zfp827
|
zinc finger protein 827
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in increased expression of ZNF827 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr19:45,624,849...45,791,739
Ensembl chr19:45,614,604...45,844,430
|
|
G
|
Zfyve16
|
zinc finger FYVE-type containing 16
|
multiple interactions
|
ISO
|
[lead acetate co-treated with zinc protoporphyrin] results in decreased expression of ZFYVE16 mRNA
|
CTD |
PMID:22839698 |
|
NCBI chr 2:25,448,264...25,495,180
Ensembl chr 2:25,448,829...25,483,295
|
|